Raymond Yurko

808 total citations
7 papers, 139 citations indexed

About

Raymond Yurko is a scholar working on Molecular Biology, Pharmacology and Computational Theory and Mathematics. According to data from OpenAlex, Raymond Yurko has authored 7 papers receiving a total of 139 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Pharmacology and 3 papers in Computational Theory and Mathematics. Recurrent topics in Raymond Yurko's work include Cholinesterase and Neurodegenerative Diseases (3 papers), Computational Drug Discovery Methods (3 papers) and RNA Interference and Gene Delivery (2 papers). Raymond Yurko is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (3 papers), Computational Drug Discovery Methods (3 papers) and RNA Interference and Gene Delivery (2 papers). Raymond Yurko collaborates with scholars based in United States. Raymond Yurko's co-authors include Courtney Rehak, Nicholas J. Izzo, Susan M. Catalano, Gary C. Look, Hank Safferstein, Gilbert M. Rishton, N. Scott Mason, Timothy N. Feinstein, Maliha Zahid and Xinxiu Xu and has published in prestigious journals such as Journal of Neurochemistry, Journal of Immunological Methods and Journal of Neuroscience Methods.

In The Last Decade

Raymond Yurko

6 papers receiving 137 citations

Peers

Raymond Yurko

MB

PHARM

CMN

PHYSI

OC

Zizheng Li United States

Juhyun Lee South Korea

Meagan L. Wisniewski United States

Krisztina Pesti Hungary

Joerg Weiske Germany

Hamad Yadikar Kuwait

Rachel L. French United States

F. Chen Canada

Jennifer K. Truong United States

Gabriel Boyle United States

Zizheng Li United States

Raymond Yurko

128 ×1.2

MB

12 ×0.4

PHARM

17 ×0.6

CMN

77 ×3.0

PHYSI

4 ×0.4

OC

Citations per year, relative to Raymond Yurko Raymond Yurko (= 1×) peers Zizheng Li

Countries citing papers authored by Raymond Yurko

Since Specialization

Citations

This map shows the geographic impact of Raymond Yurko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raymond Yurko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raymond Yurko more than expected).

Fields of papers citing papers by Raymond Yurko

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raymond Yurko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raymond Yurko. The network helps show where Raymond Yurko may publish in the future.

Co-authorship network of co-authors of Raymond Yurko

This figure shows the co-authorship network connecting the top 25 collaborators of Raymond Yurko. A scholar is included among the top collaborators of Raymond Yurko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raymond Yurko. Raymond Yurko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Wen, Jin, Raymond Yurko, Kazi Islam, et al.. (2025). Novel Lung Cell-Penetrating Peptide Targets Alveolar Epithelial Type II Cells, Basal Cells, and Ionocytes. Pharmaceutics. 17(7). 824–824.

2.

Rehak, Courtney, et al.. (2021). Modeling the mature CNS: A predictive screening platform for neurodegenerative disease drug discovery. Journal of Neuroscience Methods. 358. 109180–109180. 7 indexed citations

3.

Yurko, Raymond, Nicholas J. Izzo, Courtney Rehak, et al.. (2021). Sigma‐2 receptor antagonists rescue neuronal dysfunction induced by Parkinson’s patient brain‐derived α‐synuclein. Journal of Neuroscience Research. 99(4). 1161–1176. 33 indexed citations

4.

Rishton, Gilbert M., Gary C. Look, Zhi‐Jie Ni, et al.. (2021). Discovery of Investigational Drug CT1812, an Antagonist of the Sigma-2 Receptor Complex for Alzheimer’s Disease. ACS Medicinal Chemistry Letters. 12(9). 1389–1395. 31 indexed citations

5.

LeVine, Harry, Nicholas J. Izzo, Raymond Yurko, et al.. (2020). Alzheimer’s protection effect of A673T mutation may be driven by lower Aβ oligomer binding affinity. Journal of Neurochemistry. 157(4). 1316–1330. 18 indexed citations

6.

Zahid, Maliha, Timothy N. Feinstein, Xinxiu Xu, et al.. (2018). Cardiac Targeting Peptide, a Novel Cardiac Vector: Studies in Bio-Distribution, Imaging Application, and Mechanism of Transduction. Biomolecules. 8(4). 147–147. 39 indexed citations

7.

Montelaro, Ronald C., Mark E. Schurdak, Charles R. Rinaldo, et al.. (2016). Selection of a potential diagnostic biomarker for HIV infection from a random library of non-biological synthetic peptoid oligomers. Journal of Immunological Methods. 435. 85–89. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact